CAS No. |
863239-60-5 |
中文名称 |
N-[(R)-4-[(3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-乙基-3,7-二羟基-10,13-二甲基六十氢-1H-环戊二烯并[a]菲-17-基]戊酰基]甘氨酸 |
英文名称 |
((R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycine |
别名 |
6-Egcdca | BDBM50250872 | UNII-O2MZK6V9LQ | Glycine, N-[(3a,5b,6a,7a)-6-ethyl-3,7-dihydroxy-24-oxocholan-24-yl]- | CS-0112411 | AKOS040733278 | Glycine, N-((3alpha,5beta,6alpha,7alpha)-6-ethyl-3,7-dihydroxy-24-oxocholan-24-yl)- | SCHEMBL17734129 | HY-1354 |
标准英文名 |
((R)-4-((3R,5S,6R,7R,8S,9S,10S,13R,14S,17R)-6-ethyl-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycine |
MDL No. |
MFCD00867525 |
分子式 |
C28H47NO5 |
分子量 |
477.69
|
精确分子量 |
477.35
|
SMILES |
CC[C@H]1[C@@H](O)[C@@H]2[C@H](CC[C@]3(C)[C@@H]([C@H](C)CCC(=O)NCC(=O)O)CC[C@@H]23)[C@@]2(C)CC[C@@H](O)C[C@@H]12 |
标准SMILES |
C[C@H](CCC(=O)NCC(O)=O)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1[C@@H](CC)[C@H]3O |
用途 |
Glyco-obeticholic acid is a glycine-conjugated metabolite of obeticholic acid, formed in the liver and secreted into bile; it can be deconjugated by microorganisms in the ileum and colon to regenerate the parent drug, obeticholic acid, which may then be reabsorbed or excreted in feces; as a metabolite of obeticholic acid—an oral, bioavailable farnesoid X receptor (FXR) agonist—it plays a role in FXR-mediated regulation in the liver, ileum, and colon. |
InChIKey |
MTLPUOZJBFHNSO-FCWTVGIUSA-N |